Physicians/Investigators from the Icahn School of Medicine at Mount Sinai suspect that lung-based blood clots may play a role in severe cases of COVID-19. This potentially implies that a treatment course for COVID-19-based respiratory failure may center on a treatment...
Icahn School of Medicine
Category
Mount Sinai Investigator Finds Dupilumab Effectively Treats Keloids
Mount Sinai Researchers have discovered that dupilumab (Dupixent, Sanofi) may represent a therapeutic option for keloids as during a recent study a patient using the drug for severe disease experienced a great reduction in the size of their keloids. Recently reported...
FAMILIA Study Harlem NY Shows Promise to Address Obesity & Cardiovascular Crisis with Disease Prevention Management
A recent study sponsored by Icahn School of Medicine, Mount Sinai and the American Heart Association found that both individual and group-based heart disease prevention management courses were more beneficial for reduced patient risk than standard lifestyle...
Photothermal Cancer Therapy Destroys Tumors in Clinical Trial at Icahn School of Medicine at Mount Sinai
Rice University researchers developed a new cancer therapy using nanoparticles to heat and destroy tumors and revealed encouraging results in a clinical trial. Background Published in the journal Proceedings of the National Academy of Sciences, the study revealed that...